Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Local Stocks
Buffalo Local Index
Buffalo Local Index
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Johnson & Johnson
(NY:
JNJ
)
146.49
-1.31 (-0.89%)
Streaming Delayed Price
Updated: 2:27 PM EDT, Jun 5, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Press Releases about Johnson & Johnson
< Previous
1
2
3
4
5
6
7
8
9
...
11
12
Next >
7 Best Blue Chip Stocks to Buy Now
September 08, 2023
Blue-chip stocks are the stocks of well-known, high-quality industry leaders. Learn more about our top picks for the best blue chip stocks to buy now.
Via
MarketBeat
Global Dry Eye Syndrome Treatment Market Expected to Reach $11.26 Billion By 2030
September 08, 2023
EQNX::TICKER_START (NASDAQ:OKYO),(NYSE:ALC),(NYSE:BLCO),(NYSE:JNJ),(OTCQX:RHHBY) EQNX::TICKER_END
Via
FinancialNewsMedia
Exposures
COVID-19
3 Stocks Awaiting Winter Winds of Opportunity
September 07, 2023
The change in seasons favors specific stocks like JNJ, GOOS, and MTN, which exhibit growth patterns tied to seasonal changes.
Via
MarketBeat
Johnson & Johnson (NYSE: JNJ) is One of Monday Morning’s Most Active Stocks
August 21, 2023
Via
Investor Brand Network
Johnson & Johnson (NYSE: JNJ) Near Top of Volume Charts in Tuesday Trading
August 15, 2023
Via
Investor Brand Network
J&J Spinoff Kenvue is the New Dividend Aristocrat on the Block
September 07, 2023
Newly public company Kenvue, a spinoff from Johnson & Johnson, joins the ranks of dividend aristocrats, offering a 3.57% yield, and 2022 sales of $15 billion.
Via
MarketBeat
Topics
ETFs
How Much Pain Will Lower Medicare Prices Cause for Pharma Stocks?
September 01, 2023
Pharmaceutical stocks are holding steady as Medicare price negotiations approach, but industry diversification and innovation support future growth prospects.
Via
MarketBeat
Topics
Economy
Exposures
Interest Rates
Johnson & Johnson Announces Updated Financials and 2023 Guidance Following Completion of the Kenvue Separation
August 30, 2023
From
Johnson & Johnson
Via
Business Wire
Johnson & Johnson (NYSE: JNJ) Highlighted for Surprising Price Action
July 20, 2023
Via
Investor Brand Network
3 High Short Interest Stocks that Investors are Getting Wrong
August 25, 2023
Heavy short interest can be a sell signal, but these three stocks have bullish stories that make them attractive investments despite heavy short interest
Via
MarketBeat
Exposures
Fossil Fuels
Disney's Big Breakup? Wall Street, Iger Ponder A Magical Split
August 23, 2023
Disney is facing decisions about a potential split, with a focus on core businesses like streaming, parks, and film studios. CEO Bob Iger remains noncommittal.
Via
MarketBeat
Topics
Earnings
Exposures
Financial
Johnson & Johnson Announces Final Results of Exchange Offer and Finalizes Separation of Kenvue Inc.
August 23, 2023
From
Johnson & Johnson
Via
Business Wire
Johnson & Johnson to Participate in the Morgan Stanley 21st Annual Global Healthcare Conference
August 22, 2023
From
Johnson & Johnson
Via
Business Wire
Johnson & Johnson Announces Preliminary Results of Kenvue Inc. Exchange Offer
August 21, 2023
From
Johnson & Johnson
Via
Business Wire
Antiepileptic Drugs Market to Witness Massive Growth by 2028 : Johnson & Johnson, Sumitomo Pharma, Sanofi
August 17, 2023
Stay up to date with Antiepileptic Drugs Market research offered by HTF MI. Check how key trends and emerging drivers are shaping this industry growth.
Via
SBWire
Johnson & Johnson Announces Final Exchange Ratio of 8.0324 in Split-Off of Kenvue Inc.
August 16, 2023
From
Johnson & Johnson
Via
Business Wire
5 Best Stocks to Buy in a Bear Market
August 11, 2023
Want income-producing assets and stable stocks? Look for stocks with stable cash flow in rock-solid industries for the best stocks to buy in a bear market.
Via
MarketBeat
Topics
Economy
Exposures
Economy
3 Stocks to Play the Recovery in Digital Advertising
August 08, 2023
The slowdown in digital advertising triggered many technology stocks to sell off, notably social media platforms like Snap Inc. (NASDAQ: SNAP). However, a
Via
MarketBeat
Topics
Earnings
Exposures
Financial
Johnson & Johnson to Participate in the 2023 Wells Fargo Securities Healthcare Conference
August 07, 2023
From
Johnson & Johnson
Via
Business Wire
Rising Dividend Make Zoetis a Doggone Winner
August 03, 2023
Investors that typically focus on other large cap pharmaceutical plays may wish to consider an alternative bet on pets with shares of Zoetis.
Via
MarketBeat
Nachawati Law Group Trial Lawyers Renew Commitment to Cancer Victims After Judge’s Rejection of Johnson & Johnson’s Proposed $8.9B Settlement
July 31, 2023
From
Nachawati Law Group
Via
Business Wire
3 Consumer Discretionary Stocks That Still Have Pricing Power
July 24, 2023
Pricing power fuels earnings growth and here are three consumer discretionary stocks that have recently given investors confirmation of their pricing power
Via
MarketBeat
Topics
Economy
Exposures
Interest Rates
Kenvue To File Form S-4 Registration Statement in Connection with Johnson & Johnson Exchange Offer Announcement
July 24, 2023
From
Kenvue Inc.
Via
Business Wire
Johnson & Johnson Launches Exchange Offer for Separation of Kenvue Inc.
July 24, 2023
From
Johnson & Johnson
Via
Business Wire
MarketBeat Week in Review – 7/17 - 7/21
July 22, 2023
Investor sentiment remains strong but upcoming tech earnings and an expected interest rate hike may provide more clarity on the short-term outlook for stocks
Via
MarketBeat
Topics
Economy
Exposures
Economy
Interest Rates
Johnson & Johnson's Inflection Point: What it Means for Investors
July 20, 2023
Johnson & Johnson stock and the company show signs of strength and growth while offering value and yield relative to its peer Abbott Laboratories.
Via
MarketBeat
Exposures
COVID-19
Johnson & Johnson Reports Q2 2023 Results
July 20, 2023
From
Johnson & Johnson
Via
Business Wire
Johnson & Johnson to Participate in the UBS MedTech, Tools and Genomics Summit
July 10, 2023
From
Johnson & Johnson
Via
Business Wire
Inspire Medical Up 15% After Breakout, Analysts Say It's A Buy
July 06, 2023
Inspire Medical Systems has surged nearly 15% since its breakout, driven by positive Q1 results and FDA approvals. Analysts have a "buy" rating on the stock.
Via
MarketBeat
Exposures
Product Safety
OnderLaw Lauds Revolutionary Drug Combination that Offers Hope for Women with Ovarian Cancer
June 23, 2023
June 23, 2023 -- Drug Combination Shows Special Promise to Those Diagnosed with Johnson & Johnson Talc-Related Ovarian Cancer
Via
24-7 Press Release
< Previous
1
2
3
4
5
6
7
8
9
...
11
12
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.